Citation: | NIU Zhanyue, SHI Yanyan, LI Sizhu, XUE Yan. Characteristics of gastric microbiota in Helicobacter pylori associated chronic gastritis[J]. Journal of Clinical Medicine in Practice, 2024, 28(1): 56-61. DOI: 10.7619/jcmp.20233613 |
To investigate the characteristics and differences of gastric flora in chronic non-atrophic gastritis and chronic atrophic gastritis associated with Helicobacter pylori (H. pylori).
A prospective study was adopted, and 24 patients with chronic gastritis caused by H. pylori infection were divided into chronic non-atrophic gastritis group (n=18) and chronic atrophic gastritis group (n=6). Characteristics of gastric mucosal flora in both groups were determined, and Alpha and Beta diversity analyses and species correlation analysis were performed.
The gastric flora in both groups were mainly consisted of Proteobacteria, Bacteroidetes, Firmicutes, Actinobacteria, and Fusobacteria. Significant differences in species diversity and abundance were observed between the two groups (ANOSIM analysis, P=0.046). Fusobacterium (P=0.023), Leptotrichia (P=0.047), Prevotella (P=0.016), Sphingomonas (P=0.042), and Treponema (P=0.006) were significantly enriched in the chronic atrophic gastritis group, and H. pylori showed a decreasing trend (P=0.218). Some species of gastric mucosal flora showed negative correlations with H. pylori, and the number of species negatively associated with H. pylori in the gastric mucosal flora of chronic atrophic gastritis was significantly reduced.
In the gastric mucosa of chronic atrophic gastritis, the Fusobacterium, Leptotrichia, Prevotella, Sphingomonas, and Treponema are significantly enriched and associated with the progression of chronic gastritis.
[1] |
JIANG J X, LIU Q, MAO X Y, et al. Downward trend in the prevalence of Helicobacter pylori infections and corresponding frequent upper gastrointestinal diseases profile changes in Southeastern China between 2003 and 2012[J]. Springerplus, 2016, 5(1): 1601. doi: 10.1186/s40064-016-3185-2
|
[2] |
WANG Z, SHAO S L, XU X H, et al. Helicobacter pylori and gastric microbiota homeostasis: progress and prospects[J]. Future Microbiol, 2023, 18: 137-157. doi: 10.2217/fmb-2022-0102
|
[3] |
中华医学会消化病学分会, 中华医学会消化病学分会消化系统肿瘤协作组. 中国慢性胃炎诊治指南(2022年, 上海)[J]. 中华消化杂志, 2017, 37(11): 721-738. doi: 10.3760/cma.j.issn.0254-1432.2017.11.001
|
[4] |
DAI D F, YANG Y, YU J Q, et al. Interactions between gastric microbiota and metabolites in gastric cancer[J]. Cell Death Dis, 2021, 12(12): 1104. doi: 10.1038/s41419-021-04396-y
|
[5] |
LIATSOS C, PAPAEFTHYMIOU A, KYRIAKOS N, et al. Helicobacter pylori, gastric microbiota and gastric cancer relationship: Unrolling the tangle[J]. World J Gastrointest Oncol, 2022, 14(5): 959-972. doi: 10.4251/wjgo.v14.i5.959
|
[6] |
WANG M Q, YANG G, TIAN Y, et al. The role of the gut microbiota in gastric cancer: the immunoregulation and immunotherapy[J]. Front Immunol, 2023, 14: 1183331. doi: 10.3389/fimmu.2023.1183331
|
[7] |
ZHANG S Y, SHI D, LI M R, et al. The relationship between gastric microbiota and gastric disease[J]. Scand J Gastroenterol, 2019, 54(4): 391-396. doi: 10.1080/00365521.2019.1591499
|
[8] |
DE LA CUESTA-ZULUAGA J, KELLEY S T, CHEN Y F, et al. Age- and sex-dependent patterns of gut microbial diversity in human adults[J]. mSystems, 2019, 4(4): e00261-e00219.
|
[9] |
PENG X, YAO S Q, HUANG J, et al. Alterations in bacterial community dynamics from noncancerous to Gastric cancer[J]. Front Microbiol, 2023, 14: 1138928. doi: 10.3389/fmicb.2023.1138928
|
[10] |
EUN C S, KIM B K, HAN D S, et al. Differences in gastric mucosal microbiota profiling in patients with chronic gastritis, intestinal metaplasia, and gastric cancer using pyrosequencing methods[J]. Helicobacter, 2014, 19(6): 407-416. doi: 10.1111/hel.12145
|
[11] |
MCILVANNA E, LINDEN G J, CRAIG S G, et al. Fusobacterium nucleatum and oral cancer: a critical review[J]. BMC Cancer, 2021, 21(1): 1212. doi: 10.1186/s12885-021-08903-4
|
[12] |
ENGSTRAND L, GRAHAM D Y. Microbiome and gastric cancer[J]. Dig Dis Sci, 2020, 65(3): 865-873. doi: 10.1007/s10620-020-06101-z
|
[13] |
XIN Y W, LI X Y, ZHANG M J, et al. Fusobacterium nucleatum-induced exosomal HOTTIP promotes gastric cancer progression through the microRNA-885-3p/EphB2 axis[J]. Cancer Sci, 2023, 114(6): 2360-2374. doi: 10.1111/cas.15781
|
[14] |
陶明阳, 许宜行, 梁悦, 等. 肠道菌群代谢产物在肿瘤中的研究进展[J]. 实用临床医药杂志, 2022, 26(2): 137-141. doi: 10.7619/jcmp.20213955
|
[15] |
CASTAÑO-RODRÍGUEZ N, GOH K L, FOCK K M, et al. Dysbiosis of the microbiome in gastric carcinogenesis[J]. Sci Rep, 2017, 7(1): 15957. doi: 10.1038/s41598-017-16289-2
|
[16] |
TRAN H N H, THU T N H, NGUYEN P H, et al. Tumour microbiomes and Fusobacterium genomics in Vietnamese colorectal cancer patients[J]. NPJ Biofilms Microbiomes, 2022, 8(1): 87. doi: 10.1038/s41522-022-00351-7
|
[17] |
YANG I, WOLTEMATE S, PIAZUELO M B, et al. Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia[J]. Sci Rep, 2016, 6: 18594. doi: 10.1038/srep18594
|
[18] |
BARRA W F, SARQUIS D P, KHAYAT A S, et al. Gastric cancer microbiome[J]. Pathobiology, 2021, 88(2): 156-169. doi: 10.1159/000512833
|
[19] |
SUNG J J Y, COKER O O, CHU E, et al. Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication[J]. Gut, 2020, 69(9): 1572-1580. doi: 10.1136/gutjnl-2019-319826
|
[20] |
CHEN X H, WANG A, CHU A N, et al. Mucosa-associated microbiota in gastric cancer tissues compared with non-cancer tissues[J]. Front Microbiol, 2019, 10: 1261. doi: 10.3389/fmicb.2019.01261
|
[21] |
ZHANG X M, LI C, CAO W J, et al. Alterations of gastric microbiota in gastric cancer and precancerous stages[J]. Front Cell Infect Microbiol, 2021, 11: 559148. doi: 10.3389/fcimb.2021.559148
|
[22] |
NIEMINEN M T, LISTYARIFAH D, HAGSTRÖM J, et al. Treponema denticola chymotrypsin-like proteinase may contribute to orodigestive carcinogenesis through immunomodulation[J]. Br J Cancer, 2018, 118(3): 428-434. doi: 10.1038/bjc.2017.409
|
[23] |
WONG B C, LAM S K, WONG W M, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial[J]. JAMA, 2004, 291(2): 187-194. doi: 10.1001/jama.291.2.187
|